Celadon Pharmaceuticals PLC (CEL)

London
Currency in GBP
16.50
-0.50(-2.94%)
Closed
CEL Scorecard
Full Analysis
Quickly burning through cash
Fair Value
Day's Range
15.0019.00
52 wk Range
11.00122.50
Key Statistics
Edit
Bid/Ask
8.00 / 18.00
Prev. Close
17
Open
17
Day's Range
15-19
52 wk Range
11-122.5
Volume
42.23K
Average Volume (3m)
172.69K
1-Year Change
-85.33%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CEL Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week
Show more

Celadon Pharmaceuticals Company Profile

Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products. Its products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.

Employees
27

Compare CEL to Peers and Sector

Metrics to compare
CEL
Peers
Sector
Relationship
P/E Ratio
−2.2x−1.9x−0.7x
PEG Ratio
−0.060.000.00
Price/Book
4.7x1.7x2.6x
Price / LTM Sales
87.4x2.0x3.1x
Upside (Analyst Target)
-108.3%50.4%
Fair Value Upside
Unlock19.7%8.4%Unlock

Earnings

Latest Release
Sep 29, 2022
EPS / Forecast
-0.25 / --
Revenue / Forecast
11.26K / --
EPS Revisions
Last 90 days

FAQ

What Is the Celadon Pharmaceuticals (CEL) Stock Price Today?

The Celadon Pharmaceuticals stock price today is 16.50.

What Stock Exchange Does Celadon Pharmaceuticals Trade On?

Celadon Pharmaceuticals is listed and trades on the London stock exchange.

What Is the Stock Symbol for Celadon Pharmaceuticals?

The stock symbol for Celadon Pharmaceuticals is "CEL."

What Is the Celadon Pharmaceuticals Market Cap?

As of today, Celadon Pharmaceuticals market cap is 11.36M.

What is Celadon Pharmaceuticals Earnings Per Share?

The Celadon Pharmaceuticals EPS is -0.083.

From a Technical Analysis Perspective, Is CEL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.